Structural basis for penetration of the glycan shield of hepatitis C virus E2 glycoprotein by a broadly neutralizing human antibody.

The Journal of Biological Chemistry
Yili LiRoy A Mariuzza

Abstract

Hepatitis C virus (HCV) is a major cause of liver cirrhosis and hepatocellular carcinoma. A challenge for HCV vaccine development is to identify conserved epitopes able to elicit protective antibodies against this highly diverse virus. Glycan shielding is a mechanism by which HCV masks such epitopes on its E2 envelope glycoprotein. Antibodies to the E2 region comprising residues 412-423 (E2(412-423)) have broadly neutralizing activities. However, an adaptive mutation in this linear epitope, N417S, is associated with a glycosylation shift from Asn-417 to Asn-415 that enables HCV to escape neutralization by mAbs such as HCV1 and AP33. By contrast, the human mAb HC33.1 can neutralize virus bearing the N417S mutation. To understand how HC33.1 penetrates the glycan shield created by the glycosylation shift to Asn-415, we determined the structure of this broadly neutralizing mAb in complex with its E2(412-423) epitope to 2.0 Å resolution. The conformation of E2(412-423) bound to HC33.1 is distinct from the β-hairpin conformation of this peptide bound to HCV1 or AP33, because of disruption of the β-hairpin through interactions with the unusually long complementarity-determining region 3 of the HC33.1 heavy chain. Whereas Asn-415 is bu...Continue Reading

References

Dec 1, 1994·Protein Science : a Publication of the Protein Society·E G Hutchinson, J M Thornton
Jan 3, 1995·Proceedings of the National Academy of Sciences of the United States of America·B Imperiali, K W Rickert
Dec 20, 1993·Journal of Molecular Biology·M C Lawrence, P M Colman
Oct 3, 1998·Acta Crystallographica. Section D, Biological Crystallography·A T BrüngerG L Warren
Oct 30, 1998·Science·P PileriS Abrignani
Aug 2, 2000·Proceedings of the National Academy of Sciences of the United States of America·D G MyszkaM L Doyle
Oct 17, 2002·Proceedings of the National Academy of Sciences of the United States of America·Tanja Kortemme, David Baker
May 23, 2003·Proceedings of the National Academy of Sciences of the United States of America·Mayla HsuJane A McKeating
May 29, 2003·Biochimie·Anne Goffard, Jean Dubuisson
Mar 3, 2004·Acta Crystallographica. Section D, Biological Crystallography·Laurent C StoroniRandy J Read
Jun 16, 2005·Journal of Virology·Anne GoffardJean Dubuisson
Jun 28, 2005·Nucleic Acids Research·Andreas Bohne-Lang, Claus-Wilhelm von der Lieth
Aug 27, 2005·The Lancet Infectious Diseases·Colin W ShepardMiriam J Alter
Oct 18, 2005·Journal of Virology·Zhen-Yong KeckSteven K H Foung
Mar 23, 2006·Annual Review of Immunology·Ralph Pantophlet, Dennis R Burton
Sep 7, 2006·The Journal of Biological Chemistry·William C HwangRobert C Liddington
Jan 12, 2008·Journal of the American Society for Mass Spectrometry·Roxana E IacobKenneth B Tomer
Feb 15, 2008·The Journal of General Virology·Ania M OwsiankaArvind H Patel
Feb 12, 2009·Liver International : Official Journal of the International Association for the Study of the Liver·Daniel Lavanchy
Feb 24, 2009·Nature Structural & Molecular Biology·Jianhua SuiWayne A Marasco
May 25, 2012·Proceedings of the National Academy of Sciences of the United States of America·Leopold KongMansun Law
Oct 11, 2012·Immunological Reviews·Jean-Philippe JulienIan A Wilson
Jan 30, 2013·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·R T ChungD C Molrine

❮ Previous
Next ❯

Citations

May 2, 2015·Current Opinion in Virology·Leopold KongMansun Law
Mar 15, 2016·Journal of Biomolecular Structure & Dynamics·Daniela BaroneLuigi Vitagliano
Sep 23, 2016·Current Opinion in Virology·Brian G PierceSteven Kh Foung
Oct 30, 2016·Proceedings of the National Academy of Sciences of the United States of America·Leopold KongMansun Law
Oct 30, 2016·Proceedings of the National Academy of Sciences of the United States of America·Brian G PierceSteven K H Foung
Feb 13, 2016·PloS One·Laure IzquierdoFrancois Helle
Dec 21, 2016·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Patricia T VietheerHeidi E Drummer
Feb 29, 2020·PLoS Computational Biology·Lenka StejskalJoe Grove
Jun 29, 2018·Frontiers in Immunology·Netanel TzarumMansun Law
May 22, 2019·Journal of Immunology Research·Aneesh ThakurGregers Jungersen
Feb 23, 2020·Vaccines·Joshua D DuncanJonathan K Ball
Sep 20, 2020·International Journal of Molecular Sciences·Luisa J Ströh, Thomas Krey
Jan 31, 2018·Frontiers in Microbiology·Thomas R FuerstSteven K H Foung
Jun 30, 2018·Proceedings of the National Academy of Sciences of the United States of America·Fernando AlemanMansun Law
May 15, 2018·Frontiers in Immunology·Muriel LavieJean Dubuisson
Jul 4, 2018·Frontiers in Immunology·Luisa J StröhThomas Krey
Jul 8, 2020·Journal of Biomedical Science·Daniel Sepulveda-CrespoIsidoro Martinez
Jun 13, 2018·Frontiers in Immunology·Johnathan D Guest, Brian G Pierce
Jan 13, 2021·Proceedings of the National Academy of Sciences of the United States of America·Johnathan D GuestThomas R Fuerst
Apr 29, 2020·Cold Spring Harbor Perspectives in Medicine·Mansun Law
Apr 4, 2021·Vaccines·Rodrigo Velázquez-MoctezumaJannick Prentoe
Oct 1, 2018·Gastroenterology·Justin R BaileyAndrea L Cox
May 6, 2021·Viruses·Felicia SchlotthauerHeidi E Drummer
Jun 3, 2021·Viruses·Itai YechezkelNetanel Tzarum
Jun 3, 2021·Viruses·Johnathan D Guest, Brian G Pierce
Jun 7, 2021·Current Opinion in Virology·Madhumati SevvanaRichard J Kuhn
Jul 31, 2021·Current Opinion in Virology·Nicole FrumentoJustin R Bailey

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.